加齢黄斑変性症（AMD）の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Age Related Macular Degeneration (AMD) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00093 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、加齢黄斑変性症（AMD）の世界市場を広く調査・分析し、今後の市場展望をまとめております。加齢黄斑変性症（AMD）の種類別市場規模（ウェットAMD、ドライAMD）、用途別市場規模（男性、女性）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Novartis、F. HoffmannLa Roche、Regeneron、Pfizer、Valeant ・地域別グローバル市場分析 2015年-2020年 ・加齢黄斑変性症（AMD）の北米市場（アメリカ、カナダ、メキシコ） ・加齢黄斑変性症（AMD）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・加齢黄斑変性症（AMD）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・加齢黄斑変性症（AMD）の南米市場（ブラジル、アルゼンチン） ・加齢黄斑変性症（AMD）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ウェットAMD、ドライAMD ・用途別分析：男性、女性 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Age Related Macular Degeneration (AMD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1608.8 million by 2025, from USD 1348.9 million in 2019.

The Age Related Macular Degeneration (AMD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Age Related Macular Degeneration (AMD) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Age Related Macular Degeneration (AMD) market has been segmented into:
Wet AMD
Dry AMD

By Application, Age Related Macular Degeneration (AMD) has been segmented into:
Men
Woman

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Age Related Macular Degeneration (AMD) market presented in the report. This section sheds light on the sales growth of different regional and country-level Age Related Macular Degeneration (AMD) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Age Related Macular Degeneration (AMD) market.

The report offers in-depth assessment of the growth and other aspects of the Age Related Macular Degeneration (AMD) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Age Related Macular Degeneration (AMD) Market Share Analysis
Age Related Macular Degeneration (AMD) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Age Related Macular Degeneration (AMD) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Age Related Macular Degeneration (AMD) sales, revenue and market share for each player covered in this report.

The major players covered in Age Related Macular Degeneration (AMD) are:
Bayer
Novartis
F. HoffmannLa Roche
Regeneron
Pfizer
Valeant

レポート目次

---

Table of Contents

1 Age Related Macular Degeneration (AMD) Market Overview
1.1 Product Overview and Scope of Age Related Macular Degeneration (AMD)
1.2 Classification of Age Related Macular Degeneration (AMD) by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type in 2019
1.2.3 Wet AMD
1.2.4 Dry AMD
1.3 Global Age Related Macular Degeneration (AMD) Market by Application
1.3.1 Overview: Global Age Related Macular Degeneration (AMD) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Men
1.3.3 Woman
1.4 Global Age Related Macular Degeneration (AMD) Market by Regions
1.4.1 Global Age Related Macular Degeneration (AMD) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Age Related Macular Degeneration (AMD) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. HoffmannLa Roche
2.3.1 F. HoffmannLa Roche Details
2.3.2 F. HoffmannLa Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. HoffmannLa Roche SWOT Analysis
2.3.4 F. HoffmannLa Roche Product and Services
2.3.5 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Regeneron
2.4.1 Regeneron Details
2.4.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Regeneron SWOT Analysis
2.4.4 Regeneron Product and Services
2.4.5 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Valeant
2.6.1 Valeant Details
2.6.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Valeant SWOT Analysis
2.6.4 Valeant Product and Services
2.6.5 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Age Related Macular Degeneration (AMD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Age Related Macular Degeneration (AMD) Players Market Share
3.2.2 Top 10 Age Related Macular Degeneration (AMD) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Regions
4.2 North America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.3 Europe Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.5 South America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5 North America Age Related Macular Degeneration (AMD) Revenue by Countries
5.1 North America Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
5.2 USA Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5.3 Canada Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6 Europe Age Related Macular Degeneration (AMD) Revenue by Countries
6.1 Europe Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
6.2 Germany Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.3 UK Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.4 France Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.5 Russia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.6 Italy Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue by Countries
7.1 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
7.2 China Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.3 Japan Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.4 Korea Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.5 India Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8 South America Age Related Macular Degeneration (AMD) Revenue by Countries
8.1 South America Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
8.2 Brazil Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Age Related Macular Degeneration (AMD) by Countries
9.1 Middle East & Africa Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.3 UAE Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.5 South Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Age Related Macular Degeneration (AMD) Revenue and Market Share by Type (2015-2020)
10.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Type (2019-2024)
10.3 Wet AMD Revenue Growth Rate (2015-2025)
10.4 Dry AMD Revenue Growth Rate (2015-2025)
11 Global Age Related Macular Degeneration (AMD) Market Segment by Application
11.1 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2015-2020)
11.2 Age Related Macular Degeneration (AMD) Market Forecast by Application (2019-2024)
11.3 Men Revenue Growth (2015-2020)
11.4 Woman Revenue Growth (2015-2020)
12 Global Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2025)
12.1 Global Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2025)
12.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Regions (2021-2025)
12.3 North America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.4 Europe Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.6 South America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Age Related Macular Degeneration (AMD) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Age Related Macular Degeneration (AMD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Age Related Macular Degeneration (AMD) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Age Related Macular Degeneration (AMD) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer Corporate Information, Location and Competitors
Table 6. Bayer Age Related Macular Degeneration (AMD) Major Business
Table 7. Bayer Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 8. Bayer SWOT Analysis
Table 9. Bayer Age Related Macular Degeneration (AMD) Product and Solutions
Table 10. Bayer Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Age Related Macular Degeneration (AMD) Major Business
Table 13. Novartis Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Age Related Macular Degeneration (AMD) Product and Solutions
Table 16. Novartis Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. F. HoffmannLa Roche Corporate Information, Location and Competitors
Table 18. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Major Business
Table 19. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 20. F. HoffmannLa Roche SWOT Analysis
Table 21. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product and Solutions
Table 22. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Regeneron Corporate Information, Location and Competitors
Table 24. Regeneron Age Related Macular Degeneration (AMD) Major Business
Table 25. Regeneron Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 26. Regeneron SWOT Analysis
Table 27. Regeneron Age Related Macular Degeneration (AMD) Product and Solutions
Table 28. Regeneron Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Age Related Macular Degeneration (AMD) Major Business
Table 31. Pfizer Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Age Related Macular Degeneration (AMD) Product and Solutions
Table 34. Pfizer Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Valeant Corporate Information, Location and Competitors
Table 36. Valeant Age Related Macular Degeneration (AMD) Major Business
Table 37. Valeant Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 38. Valeant SWOT Analysis
Table 39. Valeant Age Related Macular Degeneration (AMD) Product and Solutions
Table 40. Valeant Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Players (2015-2020)
Table 42. Global Age Related Macular Degeneration (AMD) Revenue Share by Players (2015-2020)
Table 43. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)
Table 45. North America Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
Table 46. North America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Table 47. Europe Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
Table 50. South America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Table 53. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) by Type (2015-2020)
Table 54. Global Age Related Macular Degeneration (AMD) Revenue Share by Type (2015-2020)
Table 55. Global Age Related Macular Degeneration (AMD) Revenue Forecast by Type (2021-2025)
Table 56. Global Age Related Macular Degeneration (AMD) Revenue by Application (2015-2020)
Table 57. Global Age Related Macular Degeneration (AMD) Revenue Share by Application (2015-2020)
Table 58. Global Age Related Macular Degeneration (AMD) Revenue Forecast by Application (2021-2025)
Table 59. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) Picture
Figure 2. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type in 2019
Figure 3. Wet AMD Picture
Figure 4. Dry AMD Picture
Figure 5. Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2019
Figure 6. Men Picture
Figure 7. Woman Picture
Figure 8. Global Age Related Macular Degeneration (AMD) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Age Related Macular Degeneration (AMD) Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Age Related Macular Degeneration (AMD) Revenue Market Share in 2019
Figure 17. Global Top 10 Players Age Related Macular Degeneration (AMD) Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)
Figure 21. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Regions in 2018
Figure 22. North America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 23. Europe Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 25. South America Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 27. North America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 28. North America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 29. USA Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 30. Canada Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 32. Europe Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 34. Germany Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 35. UK Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 36. France Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 37. Russia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 38. Italy Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 41. China Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 42. Japan Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 43. Korea Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 44. India Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 46. South America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 47. South America Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 48. Brazil Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 53. UAE Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 56. Global Age Related Macular Degeneration (AMD) Revenue Share by Type (2015-2020)
Figure 57. Global Age Related Macular Degeneration (AMD) Revenue Share by Type in 2019
Figure 58. Global Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2021-2025)
Figure 59. Global Wet AMD Revenue Growth Rate (2015-2020)
Figure 60. Global Dry AMD Revenue Growth Rate (2015-2020)
Figure 61. Global Age Related Macular Degeneration (AMD) Revenue Share by Application (2015-2020)
Figure 62. Global Age Related Macular Degeneration (AMD) Revenue Share by Application in 2019
Figure 63. Global Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2021-2025)
Figure 64. Global Men Revenue Growth Rate (2015-2020)
Figure 65. Global Woman Revenue Growth Rate (2015-2020)
Figure 66. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Age Related Macular Degeneration (AMD) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Age Related Macular Degeneration (AMD) Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 70. Europe Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 72. South America Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---